SOLID PREPARATION OF CARIPRAZINE FOR ORAL ADMINISTRATION

The invention relates oral pharmaceutical compositions for the modified release delivery of cariprazine (trans-N-{4[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl}-N′,N′-dimethylurea) or pharmaceutically acceptable salts thereof for less than daily dosing. The invention also relates to...

Full description

Saved in:
Bibliographic Details
Main Authors DARÓCZI, Tünde Beáta, MAGOS, Zoltán, SUBA, Edit, KONTA, Melinda, RAJSZKINÉ LABOS, Ramóna
Format Patent
LanguageEnglish
Published 27.10.2021
Online AccessGet full text

Cover

More Information
Summary:The invention relates oral pharmaceutical compositions for the modified release delivery of cariprazine (trans-N-{4[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl}-N′,N′-dimethylurea) or pharmaceutically acceptable salts thereof for less than daily dosing. The invention also relates to the use of said compositions in the treatment and/or prevention of pathological conditions which require the modulation of dopamine receptors. The invention also relates to the process for the preparation of said modified release pharmaceutical compositions.
Bibliography:Application Number: ZA20190008454